OPKO Health Price to Book Ratio 2010-2025 | OPK
Historical price to book ratio values for OPKO Health (OPK) over the last 10 years. The current price to book ratio for OPKO Health as of July 18, 2025 is 0.83.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| OPKO Health Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-07-18 | 1.35 | 0.69 | |
| 2025-03-31 | 1.66 | $1.95 | 0.85 |
| 2024-12-31 | 1.47 | $2.03 | 0.72 |
| 2024-09-30 | 1.49 | $2.06 | 0.72 |
| 2024-06-30 | 1.25 | $2.00 | 0.62 |
| 2024-03-31 | 1.20 | $1.80 | 0.67 |
| 2023-12-31 | 1.51 | $1.85 | 0.82 |
| 2023-09-30 | 1.60 | $1.87 | 0.86 |
| 2023-06-30 | 2.17 | $1.99 | 1.09 |
| 2023-03-31 | 1.46 | $2.01 | 0.73 |
| 2022-12-31 | 1.25 | $2.02 | 0.62 |
| 2022-09-30 | 1.89 | $2.11 | 0.90 |
| 2022-06-30 | 2.53 | $2.23 | 1.14 |
| 2022-03-31 | 3.44 | $2.37 | 1.45 |
| 2021-12-31 | 4.81 | $2.47 | 1.95 |
| 2021-09-30 | 3.65 | $2.59 | 1.41 |
| 2021-06-30 | 4.05 | $2.56 | 1.58 |
| 2021-03-31 | 4.29 | $2.53 | 1.69 |
| 2020-12-31 | 3.95 | $2.49 | 1.58 |
| 2020-09-30 | 3.69 | $2.42 | 1.52 |
| 2020-06-30 | 3.41 | $2.37 | 1.44 |
| 2020-03-31 | 1.34 | $2.31 | 0.58 |
| 2019-12-31 | 1.47 | $2.41 | 0.61 |
| 2019-09-30 | 2.09 | $2.67 | 0.78 |
| 2019-06-30 | 2.44 | $2.78 | 0.88 |
| 2019-03-31 | 2.61 | $2.86 | 0.91 |
| 2018-12-31 | 3.01 | $3.06 | 0.99 |
| 2018-09-30 | 3.46 | $3.20 | 1.08 |
| 2018-06-30 | 4.70 | $3.24 | 1.45 |
| 2018-03-31 | 3.17 | $3.26 | 0.97 |
| 2017-12-31 | 4.90 | $3.30 | 1.49 |
| 2017-09-30 | 6.86 | $3.73 | 1.84 |
| 2017-06-30 | 6.58 | $3.77 | 1.75 |
| 2017-03-31 | 8.00 | $3.77 | 2.12 |
| 2016-12-31 | 9.30 | $3.75 | 2.48 |
| 2016-09-30 | 10.59 | $3.78 | 2.80 |
| 2016-06-30 | 9.34 | $3.68 | 2.54 |
| 2016-03-31 | 10.39 | $3.65 | 2.85 |
| 2015-12-31 | 10.05 | $3.63 | 2.77 |
| 2015-09-30 | 8.41 | $3.61 | 2.33 |
| 2015-06-30 | 16.08 | $1.78 | 9.01 |
| 2015-03-31 | 14.17 | $1.77 | 7.99 |
| 2014-12-31 | 9.99 | $1.93 | 5.17 |
| 2014-09-30 | 8.51 | $2.06 | 4.14 |
| 2014-06-30 | 8.84 | $2.14 | 4.12 |
| 2014-03-31 | 9.32 | $2.01 | 4.63 |
| 2013-12-31 | 8.44 | $2.12 | 3.99 |
| 2013-09-30 | 8.81 | $2.13 | 4.13 |
| 2013-06-30 | 7.10 | $0.93 | 7.65 |
| 2013-03-31 | 7.63 | $0.95 | 8.03 |
| 2012-12-31 | 4.81 | $0.59 | 8.15 |
| 2012-09-30 | 4.18 | $0.49 | 8.45 |
| 2012-06-30 | 4.60 | $0.51 | 8.97 |
| 2012-03-31 | 4.73 | $0.53 | 9.01 |
| 2011-12-31 | 4.90 | $0.54 | 9.06 |
| 2011-09-30 | 4.33 | $0.36 | 12.07 |
| 2011-06-30 | 3.69 | $0.39 | 9.56 |
| 2011-03-31 | 3.73 | $0.43 | 8.60 |
| 2010-12-31 | 3.67 | $0.09 | 40.64 |
| 2010-09-30 | 2.24 | $0.08 | 28.39 |
| 2010-06-30 | 2.26 | $0.20 | 11.52 |
| 2010-03-31 | 1.98 | $0.22 | 9.05 |
| 2009-12-31 | 1.83 | $0.12 | 14.70 |
| 2009-09-30 | 2.28 | $0.25 | 8.99 |
| 2009-06-30 | 1.77 | $0.15 | 11.49 |
| 2009-03-31 | 0.98 | $-0.04 | -25.26 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.094B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $185.001B | 81.03 |
| Thermo Fisher Scientific (TMO) | United States | $160.427B | 19.41 |
| Edwards Lifesciences (EW) | United States | $44.687B | 29.30 |
| Alcon (ALC) | Switzerland | $42.893B | 28.99 |
| IDEXX Laboratories (IDXX) | United States | $41.716B | 47.94 |
| DexCom (DXCM) | United States | $32.976B | 50.97 |
| IQVIA Holdings (IQV) | United States | $28.242B | 15.82 |
| Mettler-Toledo (MTD) | United States | $25.057B | 29.80 |
| STERIS (STE) | Ireland | $22.093B | 24.33 |
| Waters (WAT) | United States | $17.669B | 24.93 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.026B | 0.00 |
| Hologic (HOLX) | United States | $14.267B | 15.50 |
| Sysmex ADR (SSMXY) | Japan | $10.575B | 30.00 |
| Penumbra (PEN) | United States | $8.911B | 69.94 |
| Masimo (MASI) | United States | $8.586B | 31.67 |
| Globus Medical (GMED) | United States | $7.791B | 18.57 |
| Glaukos (GKOS) | United States | $5.657B | 0.00 |
| Teleflex (TFX) | United States | $5.019B | 8.29 |
| Integer Holdings (ITGR) | United States | $4.000B | 20.96 |
| TransMedics (TMDX) | United States | $3.806B | 82.74 |
| PROCEPT BioRobotics (PRCT) | United States | $3.261B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.320B | 13.81 |
| Nihon Kohden (NHNKY) | Japan | $2.042B | 23.42 |
| Veracyte (VCYT) | United States | $1.897B | 26.61 |
| Elekta AB (EKTAY) | Sweden | $1.876B | 16.86 |
| Alphatec Holdings (ATEC) | United States | $1.554B | 0.00 |
| Artivion (AORT) | United States | $1.317B | 123.40 |
| Pulse Biosciences (PLSE) | United States | $1.053B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.023B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.931B | 4.95 |
| IRadimed (IRMD) | United States | $0.730B | 37.06 |
| SiBone (SIBN) | United States | $0.713B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.597B | 12.94 |
| Beta Bionics (BBNX) | United States | $0.571B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.550B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.538B | 8.37 |
| AxoGen (AXGN) | United States | $0.530B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.425B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.417B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.413B | 9.61 |
| Delcath Systems (DCTH) | United States | $0.394B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.364B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.355B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.319B | 0.00 |
| RxSight (RXST) | United States | $0.300B | 0.00 |
| NeuroPace (NPCE) | United States | $0.298B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| Neuronetics (STIM) | United States | $0.253B | 0.00 |
| 908 Devices (MASS) | United States | $0.243B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.233B | 14.10 |
| CVRx (CVRX) | United States | $0.218B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.207B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.180B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.170B | 0.00 |
| LENSAR (LNSR) | United States | $0.156B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.151B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.130B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.123B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.113B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.112B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.092B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| Hyperfine (HYPR) | United States | $0.080B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.073B | 44.40 |
| Spectral AI (MDAI) | United States | $0.068B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.060B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.058B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.058B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 21.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.023B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.021B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.42 |